Re-purposed drugs could reverse blood vessel damage in diabetes EP News Bureau Jun 29, 2020 In a breakthrough, scientists have discovered a key mechanism that triggers changes in the blood vessels, which can eventually…
Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for… EP News Bureau Jun 1, 2020 Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market EP News Bureau Dec 4, 2019 Zomelis is used in the treatment of type 2 diabetes and comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors
Alembic Pharma gets tentative nod from USFDA for glycemic control drug Press Trust of India Jul 29, 2019 Quoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months,…